{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:28:13Z","timestamp":1791282493061,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s11914-009-0004-5","type":"journal-article","created":{"date-parts":[[2009,3,6]],"date-time":"2009-03-06T19:25:06Z","timestamp":1236367506000},"page":"18-22","source":"Crossref","is-referenced-by-count":111,"title":["Denosumab: Anti-RANKL antibody"],"prefix":"10.1007","volume":"7","author":[{"given":"Paul D.","family":"Miller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,8]]},"reference":[{"key":"4_CR1","first-page":"58","volume-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism","author":"D.B. Burr","year":"2003","unstructured":"Burr DB, Turner CH: Biomechanics of bone. In Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Edited by Favus M. Washington, DC: American Society for Bone and Mineral Research; 2003:58\u201364."},{"issue":"Suppl5","key":"4_CR2","first-page":"S12","volume":"14","author":"R. Heaney","year":"2003","unstructured":"Heaney R: Remodeling and skeletal fragility. Osteoporos Int 2003, 14(Suppl 5):S12\u2013S15.","journal-title":"Osteoporos Int"},{"key":"4_CR3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bone.2008.03.025","volume":"43","author":"P. Pivonka","year":"2008","unstructured":"Pivonka P, Zimak J, Smith DW, et al.: Model structure and control of bone remodeling: a theoretical study. Bone 2008, 43:249\u2013263.","journal-title":"Bone"},{"key":"4_CR4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1359\/JBMR.0301226","volume":"19","author":"J.C. Huang","year":"2004","unstructured":"Huang JC, Sakata T, Pfleger LL, et al.: PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 2004, 19:235\u2013244.","journal-title":"J Bone Miner Res"},{"key":"4_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"W.J. Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL: Osteoclast differentiation and activation. Nature 2003, 423:337\u2013342.","journal-title":"Nature"},{"key":"4_CR6","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","volume":"19","author":"P.J. Bekker","year":"2004","unstructured":"Bekker PJ, Holloway DL, Rasmussen AS, et al.: Single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women. J Bone Miner Res 2004, 19:1059\u20131066.","journal-title":"J Bone Miner Res"},{"key":"4_CR7","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2007.12.224","volume":"42","author":"L.F. Bonewald","year":"2008","unstructured":"Bonewald LF, Johnson ML: Osteocytes, mechanosensing, and Wnt signaling. Bone 2008, 42:606\u2013615.","journal-title":"Bone"},{"key":"4_CR8","first-page":"239","volume":"2","author":"L.F. Bonewald","year":"2002","unstructured":"Bonewald LF: Osteocytes: a proposed multifunctional bone cell. J Musculoskelet Neuronal Interact 2002, 2:239\u2013241.","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"4_CR9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.abb.2008.03.006","volume":"473","author":"E. Piters","year":"2008","unstructured":"Piters E, Boudin E, Van Hul W: Wnt signaling: a win for bone. Arch Biochem Biophys 2008, 473:112\u2013116.","journal-title":"Arch Biochem Biophys"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2106\/JBJS.G.01183","volume":"90","author":"P. Dijke ten","year":"2008","unstructured":"ten Dijke P, Krause C, de Gorter DJ, et al.: Osteocytederived sclerostin inhibits bone formation: its role in bone morphogenetic protein and Wnt signaling. J Bone Joint Surg Am 2008, 90:31\u201335.","journal-title":"J Bone Joint Surg Am"},{"key":"4_CR11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/BOR.0b013e3283025e9c","volume":"20","author":"G. Duque","year":"2008","unstructured":"Duque G: Bone and fat connection in aging bone. Curr Opin Rheumatol 2008, 20:429\u2013434.","journal-title":"Curr Opin Rheumatol"},{"key":"4_CR12","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/ncprheum0070","volume":"2","author":"C.J. Rosen","year":"2006","unstructured":"Rosen CJ, Bouxsein ML: Mechanisms of disease: is osteoporosis the obesity of bone? Nat Clin Pract Rheumatol 2006, 2:35\u201343.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"4_CR13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semarthrit.2006.04.001","volume":"36","author":"K.S. Davison","year":"2006","unstructured":"Davison KS, Siminoski K, Adachi JD, et al.: The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future. Semin Arthritis Rheum 2006, 36:10\u201321.","journal-title":"Semin Arthritis Rheum"},{"key":"4_CR14","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","volume":"354","author":"M.R. McClung","year":"2006","unstructured":"McClung MR, Lewiecki EM, Cohen SB, et al.: Denosumab in postmenopausal women with low bone mineral density. N Engl J Med 2006, 354:821\u2013831.","journal-title":"N Engl J Med"},{"key":"4_CR15","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1359\/jbmr.070809","volume":"22","author":"E.M. Lewiecki","year":"2007","unstructured":"Lewiecki EM, Miller PD, McClung MR, et al.: Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD. J Bone Miner Res 2007, 22:1832\u20131841.","journal-title":"J Bone Miner Res"},{"key":"4_CR16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2008.04.007","volume":"43","author":"P.D. Miller","year":"2008","unstructured":"Miller PD, Bolognese MA, Lewiecki EM, et al.: Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: a randomized blinded phase 2 clinical trial. Bone 2008, 43:222\u2013229.","journal-title":"Bone"},{"key":"4_CR17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/ar.a.10119","volume":"275","author":"H. Frost","year":"2003","unstructured":"Frost H: Bone\u2019s mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 2003, 275:1081\u20131101.","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"4_CR18","doi-asserted-by":"crossref","unstructured":"Genant HK, Engelke K, Brown JP, et al.: Denosumab improves forearm densitometric, geometric and strength indices as measured by QCT in postmenopausal women with low BMD. Presented at the 35th European Symposium on Calcified Tissues. Barcelona, Spain; May 24\u201328, 2008.","DOI":"10.1016\/j.jocd.2008.07.075"},{"key":"4_CR19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.AOG.0000114986.14806.37","volume":"103","author":"J. Yates","year":"2004","unstructured":"Yates J, Barrett-Conner E, Barlas S, et al.: Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment. Obstet Gynecol 2004, 103:440\u2013446.","journal-title":"Obstet Gynecol"},{"key":"4_CR20","unstructured":"Cummings SR, McClung MR, Christiansen C, et al.: A phase III study of the effects of denosumab on vertebral, non-vertebral, and hip fractures: results from the freedom trial. J Bone Miner Res 2009 (in press)."},{"key":"4_CR21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S8756-3282(01)00433-1","volume":"28","author":"T. Mashiba","year":"2001","unstructured":"Mashiba T, Burr DB, Turner CH, et al.: Effects of human parathyroid hormone (1\u201334) LY333334, on bone mass, remodeling, and mechanical properties of cortical bone during the first remodeling cycle of rabbits. Bone 2001, 28:538\u2013547.","journal-title":"Bone"},{"key":"4_CR22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11914-005-0023-9","volume":"3","author":"D.B. Burr","year":"2005","unstructured":"Burr DB: Does early PTH treatment compromise bone strength? The balance between remodeling, porosity, bone mineral and bone size. Curr Osteoporos Rep 2005, 3:19\u201324.","journal-title":"Curr Osteoporos Rep"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0004-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11914-009-0004-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-009-0004-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T20:33:44Z","timestamp":1559421224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11914-009-0004-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["4"],"URL":"https:\/\/doi.org\/10.1007\/s11914-009-0004-5","relation":{},"ISSN":["1544-1873","1544-2241"],"issn-type":[{"value":"1544-1873","type":"print"},{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}